Breaking News

Fujifilm Diosynth Biotechnologies Completes Facility Expansion in CA

Upgrades its development labs and adds two new independent cell therapy production suites, significantly increasing cleanroom capacity for new client programs.

Author Image

By: Charlie Sternberg

Associate Editor

Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO), has completed an expansion of its cell therapy manufacturing facility in Thousand Oaks, California. The event also celebrated the recent European Medicines Agency (EMA) site issuance of a Certificate of GMP Compliance of a Manufacturer.   This expansion upgrades the development labs and adds two new independent cell therapy production suites, significantly increasing cleanroom capacity for new clie...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters